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Most BsMAbs are derived from the IgG class, whereas most hybridomas raised against carbohydrate antigens, including the tumor-associated antigens, are IgM MAb producers. IgM antibody-enzyme conjugates are of limited use in enzyme immunoassays because of steric effects, reduction of their activities, and high nonspecific binding. For these reasons, BsMAbs prepared from IgM MAbs have been especially used for cancer immunodiagnosis. Their production by hybrid-hybridoma fusion is one method (7 ) , but it is not an effective one. F(abЈ) 2 fragments have been successfully prepared from their IgMs, and their performance has been evaluated (8 -11 ) . In this report, homogeneous bispecific F(abЈ) 2 fragments (BsF fragments) were efficiently prepared from IgMs.
Mouse IgM monoclonal antibodies 9CA10 and APM05 recognize carcinoembryonic antigen (CEA) and calf intestine alkaline phosphatase (AP), respectively. Their F(abЈ) 2 fragments were prepared by pepsin digestion and purified by hydrophobic interaction HPLC (8, 10, 11 ) . The purities of the fragments from the IgMs were Ͼ96% by size exclusion HPLC using a TSKgel G3000SW XL column (7.8 mm i.d ϫ 30 cm; Tosoh), and the yields were 54% (APM05) and 53% (9CA10), respectively. The F(abЈ) 2 of 9CA10 was reduced to FabЈ -SH with 50 mmol/L 2-mercaptoethylamine (Sigma) in phosphate-buffered saline (PBS) containing 10 mmol/L EDTA at 37°C for 1 h, and was separated from 2-mercaptoethylamine by size exclusion HPLC on a TSKgel G3000SW XL column. Immediately after HPLC, the FabЈ -SH was converted to a thionitrobenzonic acid (TNB) derivative with dithionitrobenzene, and FabЈ -TNB was applied to a TSKgel G3000SW XL column to remove any excess TNB and dithionitrobenzene. FabЈ -TNB (9CA10) was reacted with FabЈ-SH (APM05) to form SOS bonds between FabЈ (9CA10) and FabЈ (APM05) at a molar ratio of 2.5:1, followed by incubation at 4°C for 16 h under N 2 gas. Ammonium sulfate (70% saturation) was added to the reaction mixture, and the mixture was centrifuged at 10 000g for 20 min. The precipitate was dissolved with 50 mmol/L phosphate buffer (pH 7.4) containing 2.0 mol/L ammonium sulfate. The solution was applied to a TSKgel Ether-5PW column (7.5 mm i.d. ϫ 7.5 cm; Tosoh) equilibrated with the same buffer and eluted with a linear gradient of ammonium sulfate from 2.0 to 0 mol/L at a flow rate of 0.5 mL/min. Three peaks were eluted at 32 min (peak 1), 40 min (peak 2), and 46 min (peak 3). The proteins of peaks 1 and 3 were FabЈ -TNB and FabЈ -SH, respectively. The protein eluted in peak 2 showed immunoreactivities against both antigens (data not shown) and was identified as BsF . The elution time of peak 2 suggests that the hydrophobicity of the BsF fragment is the average of those of the parental F(abЈ) 2 fragments. The BsF fragments were purified to homogeneity in a onestep procedure using hydrophobic interaction HPLC (Fig.  1A) , and the final yields of the BsF fragments were 35-40% of the theoretical values.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed in a 6% slab gel under nonreducing conditions (12 ) , and the proteins were stained with Coomassie Brilliant Blue R-250. The BsF fragment and its parental F(abЈ) 2 fragments showed a similar migration pattern (144 -146 kDa) during SDS-PAGE, suggesting that the BsF is composed of four chains [two pairs of a truncated heavy chain and an intact light chain derived from the parental F(abЈ) 2 ]. (A), elution was monitored by measuring absorbance at 280 nm. The BsF peak is indicated by an arrow. (B), 100 L of anti-CEA IgM covalently labeled with AP (Ⅺ), anti-CEA F(abЈ) 2 fragment covalently labeled with AP (E), or BsF bound to AP (‚) was added to the well, followed by the addition of 100 L of CEA solution at the concentration indicated on the x axis. p-Nitrophenylphosphate was added, and the absorbance at 405 nm was measured.
The dissociation constants (K D ) of the BsF and its parental F(abЈ) 2 fragments with their specific antigens were measured by surface plasmon resonance using a BIAcore biosensor (Pharmacia Biosensor). The BsF and its parental F(abЈ) 2 fragments were injected separately and immobilized on the chip coated with goat anti-mouse (IgG ϩ IgM) antibodies (Jackson ImmunoResearch Laboratories). When CEA (50 mg/L; Scripps Laboratories) was injected on the chips coated with BsF or its parental F(abЈ) 2 fragments, the intensities increased 29 and 30 relative response units, respectively. The intensities of BsF (50 mg/L) and its parental F(abЈ) 2 fragments (50 mg/L) against AP increased 23 and 24 relative response units, respectively. For CEA, the K D s were 249 nmol/L (BsF ) and 212 nmol/L [F(abЈ) 2 (9CA10)], respectively. The K D s against AP were 13 nmol/L (BsF ) and 10 nmol/L [F(abЈ) 2 (APM05)], respectively.
The immunoreactivity of BsF bound to AP was evaluated by sandwich enzyme immunoassay and compared with that of the F(abЈ) 2 covalently conjugated to AP. A 96-well microtiter plate (Nunc-intermed; MaxiSorp) was coated with goat anti-CEA polyclonal antibody (prepared in our laboratory) and blocked by incubation with 2 g/L bovine serum albumin in PBS (pH 7.4). After washing, the plate was incubated at 25°C for 60 min with 100 L of CEA at various concentrations (0, 25, 50, 100, 200, 400 g/L) and 100 L of the BsF bound to AP (absorbance at 280 nm in PBS ϭ 0.004), IgM covalently labeled with AP (absorbance at 280 nm in PBS ϭ 0.002), or F(abЈ) 2 covalently labeled with AP (A 280 nm in PBS ϭ 0.004). After another washing, 100 L of the substrate solution (2 g/L p-nitrophenylphosphate in 50 mmol/L carbonate buffer, pH 9.5, containing 10 mmol/L MgCl 2 ) was added to the plate for 20 min at 25°C, and the reaction was terminated by adding 100 L of 0.5 mol/L NaOH. The AP activity was measured by the absorbance at 405 nm (Fig. 1B) . The detection limits of the CEA assay (defined as 2 SD above the zero concentration calibrator) were 0.90 g/L for BsF and 3.4 g/L for F(abЈ) 2 , respectively. The immunoreactivity of BsF against CEA was almost the same as that of the F(abЈ) 2 covalently labeled with AP in the range 0.90 -400 g/L. The nonspecific binding of BsF was 27% (0.90 ϫ 100/3.4 ϭ 27) lower than that of F(abЈ) 2 .
Because the covalently labeled conjugate that was prepared from F(abЈ) 2 and AP is a complex polymer molecule and has multiple antigen binding sites in one conjugate molecule, the conjugate cannot bind to the antigen at a molar ratio of 1:1. The BsF bound to the AP conjugate can bind more efficiently to the antigen at a 1:1 molar ratio. To detect lower concentrations of the antigen, BsF may be more useful than the covalently labeled conjugate. The BsF bound to the AP conjugate was stable for at least 3 months at 4°C.
In conclusion, we showed that homogeneous BsF fragments prepared from IgMs recognized both antigens without any loss in immunoreactivity. The BsF bound to AP allowed sensitive and reliable measurement of the antigen and may be generally applicable for immunodiagnosis. Infrared (IR) spectroscopy offers an approach to clinical analysis that is conceptually very appealing. Whereas countless assays rely on the use of chemical agents to "recognize" the analyte of interest and to react with the analyte to produce specific color changes, IR-based analysis is founded on the rich IR absorption patterns that characterize the analytes themselves. These absorption patterns provide the basis to distinguish among the constituents and to separately quantify them. The most obvious distinguishing feature is that no reagents are required. In addition, IR-based analytical methods require very small sample volumes (typically microliters), show good precision over the entire physiological range, and are well suited for automation.
Several previous studies have illustrated potential roles for IR spectroscopy in the clinical laboratory. For example,
